Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

NCT05509400 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

813

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Rimegepant
DRUG: Placebo
DRUG: Rimegepant

Sponsor

Pfizer